Fourteen patients with chronic myeloid leukemia (CML) relapsing after allogeneic bone
marrow transplant (BMT) were treated with leukocyte transfusions from the original marrow …

PURPOSE Treatment options for patients with chronic myeloid leukemia (CML) who relapse
after allogeneic bone marrow transplantation (BMT) are limited. Treatment with lymphocytes …

Eight patients who had hematologic relapse of chronic myelogenous leukemia (CML) after
undergoing allogeneic bone marrow transplantation (BMT) were treated with leukocyte …

Relapse of the underlying disease remains the most frequent cause of treatment failure.
Although survival after allogeneic BMT has improved over the last decade, this has been …

The purpose of this study was to determine the long-term results of allogeneic bone marrow
transplantation for chronic myeloid leukemia. A retrospective analysis was carried out of the …

Relapse remains a significant problem after allogeneic bone marrow transplantation (BMT).
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …

Allogeneic bone marrow transplantation is an effective treatment of leukemia. Intensive
chemo‐and radiotherapy used for conditioning and T‐cells of the graft contribute to the …

We studied the clinical course of 130 chronic myeloid leukemia (CML) patients (89 males
and 41 females) in the European Bone Marrow Transplantation Group (EBMT) registry who …

Allogeneic bone marrow transplantation (BMT) is the only curative therapy for chronic
myeloid leukemia (CML), but relapse occurs in approximately 10% of patients transplanted …

We analysed the incidence of graft failure, graft‐versus‐host disease (GVHD) and relapse of
leukaemia in 208 patients undergoing allogeneic bone marrow transplantation (BMT) for …